Latest Breaking News On - Specialised therapeutics asia - Page 1 : comparemela.com

Deal aims to bring edaravone for ALS to Australia, New Zealand | Treeway partners with ST Asia on therapy, sold in US as Radicava

Deal aims to bring edaravone for ALS to Australia, New Zealand | Treeway partners with ST Asia on therapy, sold in US as Radicava
alsnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alsnewstoday.com Daily Mail and Mail on Sunday newspapers.

New zealandSouth australiaSusan mathersGethin thomasMonash healthMonash university school of clinical sciencesSpecialised therapeutics asiaMonash universityClinical sciencesRating scale revised

NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE

Singapore's Health Sciences Authority (HSA) has approved QINLOCK® (ripretinib) for the treatment of patients with 4th line GIST QINLOCK significantly reduced the risk of disease progression or death by 85% and showed clinically meaningful overall survival in the INVICTUS Phase 3 Study1,2 SINGAPORE, May 8, 2023 /PRNewswire/ Independent biopharmaceutical company Specialised Therapeutics Asia (ST) is pleased to.

New zealandCarlo montagnerSouth east asiaRichard quekDeciphera pharmaceuticalsSingapore health sciences authorityCorporate affairs emma powerHealth sciences authorityEuropean society for medical oncology virtual meetingGi cancer institute australiaSpecialised therapeutics asiaExecutive officer carlo montagnerManager communicationsSpecialised therapeuticsResponse evaluation criteriaSolid tumors

NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE

NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New zealandSouth east asiaRichard quekCarlo montagnerGi cancer institute australiaEuropean society for medical oncology virtual meetingCorporate affairs emma powerDeciphera pharmaceuticalsSingapore health sciences authorityHealth sciences authoritySpecialised therapeutics asiaBlinded independent central reviewResponse evaluation criteriaSolid tumorsManager communicationsSpecialised therapeutics

NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE

/PRNewswire/ Independent biopharmaceutical company Specialised Therapeutics Asia (ST) is pleased to announce that a new therapy to treat rare.

New zealandRichard quekSouth east asiaCarlo montagnerHealth sciences authorityEuropean society for medical oncology virtual meetingSingapore health sciences authorityDeciphera pharmaceuticalsCorporate affairs emma powerGi cancer institute australiaSpecialised therapeutics asiaExecutive officer carlo montagnerManager communicationsSpecialised therapeuticsResponse evaluation criteriaSolid tumors

GLOBAL SARCOMA THERAPY NOW APPROVED FOR NEW ZEALAND PATIENTS

/PRNewswire/ Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce that its portfolio therapy to treat rare soft tissue.

United statesNew zealandCarlo montagnerDenise carusoJayesh desaiAustralia therapeutic goods administrationCancer council victoria fact sheetEuropean medicines agency summary of product characteristicsZealand sarcoma associationSpecialised therapeuticsAssociate professor jayesh desaiMedical oncologistDeputy chairNew zealand sarcoma associationExecutive officer dr denise carusoTherapeutic goods administration